Helicase-like transcription factor expression is associated with a poor prognosis in Non-Small-Cell Lung Cancer (NSCLC)

BACKGROUND: The relapse rate in early stage non-small cell lung cancer (NSCLC) after surgical resection is high. Prognostic biomarkers may help identify patients who may benefit from additional therapy. The Helicase-like Transcription Factor (HLTF) is a tumor suppressor, altered in cancer either by...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Cancer
Autori principali: Dhont, Ludovic, Pintilie, Melania, Kaufman, Ethan, Navab, Roya, Tam, Shirley, Burny, Arsène, Shepherd, Frances, Belayew, Alexandra, Tsao, Ming-Sound, Mascaux, Céline
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2018
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5902896/
https://ncbi.nlm.nih.gov/pubmed/29661164
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4215-y
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi